# Blood Podcast

Page: https://stenobird.com/podcast/blood-podcast-664776
Text version: https://stenobird.com/podcast/blood-podcast-664776.md
RSS feed: https://feeds.transistor.fm/blood-podcast
Author: American Society of Hematology
Episodes: 388

## Resource

The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.

## Machine-readable

JSON: https://stenobird.com/v1/public/podcasts/blood-podcast-664776
Markdown: https://stenobird.com/podcast/blood-podcast-664776.md

## Episodes
- [IV Iron during Acute Infection and Revisiting iTTP Refractoriness](https://stenobird.com/podcast/blood-podcast-664776/iv-iron-during-acute-infection-and-revisiting-ittp-refractoriness) — 2026-07-16T16:00:00+00:00
- [A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies](https://stenobird.com/podcast/blood-podcast-664776/a-pediatric-itp-risk-model-and-targeting-cd2-with-car-t-cell-therapies) — 2026-07-09T16:00:00+00:00
- [IV Iron Risks and Low-Dose AML Gains](https://stenobird.com/podcast/blood-podcast-664776/iv-iron-risks-and-low-dose-aml-gains) — 2026-07-02T16:00:00+00:00
- [Orca-T for GVHD–free survival and Understanding VEXAS anemia](https://stenobird.com/podcast/blood-podcast-664776/orca-t-for-gvhd-free-survival-and-understanding-vexas-anemia) — 2026-06-25T16:00:00+00:00
- [Treating AML, Before and After Relapse](https://stenobird.com/podcast/blood-podcast-664776/treating-aml-before-and-after-relapse) — 2026-06-18T16:00:00+00:00
- [Future Directions in Relapsed and Refractory Large B-cell Lymphoma](https://stenobird.com/podcast/blood-podcast-664776/future-directions-in-relapsed-and-refractory-large-b-cell-lymphoma) — 2026-06-11T16:00:00+00:00
- [Review Series on Clonal Tracking in Hematopoiesis](https://stenobird.com/podcast/blood-podcast-664776/review-series-on-clonal-tracking-in-hematopoiesis) — 2026-06-04T16:00:17+00:00
- [New Approaches: Marstacimab Therapy and HLH Biomarkers](https://stenobird.com/podcast/blood-podcast-664776/new-approaches-marstacimab-therapy-and-hlh-biomarkers) — 2026-05-28T16:00:00+00:00
- [Review Series on Hemophagocytic Lymphohistiocytosis (HLH)](https://stenobird.com/podcast/blood-podcast-664776/review-series-on-hemophagocytic-lymphohistiocytosis-hlh) — 2026-05-21T16:00:00+00:00
- [IBD augmentation of CHIP and Platelet mTOR's impact on Cerebral Malaria](https://stenobird.com/podcast/blood-podcast-664776/ibd-augmentation-of-chip-and-platelet-mtor-s-impact-on-cerebral-malaria) — 2026-05-14T16:00:36+00:00
- [Long-term efficacy and safety of betibeglogene autotemcel for β-thalassemia](https://stenobird.com/podcast/blood-podcast-664776/long-term-efficacy-and-safety-of-betibeglogene-autotemcel-for-thalassemia) — 2026-05-07T16:00:00+00:00
- [Effects of ZNF467 on HSPC fitness and Promotion of Follicular Lymphoma via DC-SIGN](https://stenobird.com/podcast/blood-podcast-664776/effects-of-znf467-on-hspc-fitness-and-promotion-of-follicular-lymphoma-via-dc-sign) — 2026-04-30T16:00:00+00:00
- [Pathophysiology of ANKRD26-related thrombocytopenia and B-ALL recurrence after blinatumomab](https://stenobird.com/podcast/blood-podcast-664776/pathophysiology-of-ankrd26-related-thrombocytopenia-and-b-all-recurrence-after-blinatumomab) — 2026-04-23T16:00:00+00:00
- [Real-world availability of CAR T-cell therapies](https://stenobird.com/podcast/blood-podcast-664776/real-world-availability-of-car-t-cell-therapies) — 2026-04-16T16:33:22+00:00
- [Consequences of p53 loss and Gastrin for aGVHD of the Stomach](https://stenobird.com/podcast/blood-podcast-664776/consequences-of-p53-loss-and-gastrin-for-agvhd-of-the-stomach) — 2026-04-09T16:00:00+00:00
- [Review Series on Myeloproliferative Neoplasms](https://stenobird.com/podcast/blood-podcast-664776/review-series-on-myeloproliferative-neoplasms) — 2026-04-02T16:06:14+00:00
- [CH in children with SCD and Asciminib for CML in the ASC4FIRST trial](https://stenobird.com/podcast/blood-podcast-664776/ch-in-children-with-scd-and-asciminib-for-cml-in-the-asc4first-trial) — 2026-03-26T16:43:47+00:00
- [Emerging Mechanisms: Neutrophils and Immune thrombocytopenia from ICI](https://stenobird.com/podcast/blood-podcast-664776/emerging-mechanisms-neutrophils-and-immune-thrombocytopenia-from-ici) — 2026-03-19T16:00:00+00:00
- [Hepcidin-DMT1 interaction and GPRC5D-targeting bispecific antibody for MM](https://stenobird.com/podcast/blood-podcast-664776/hepcidin-dmt1-interaction-and-gprc5d-targeting-bispecific-antibody-for-mm) — 2026-03-12T16:00:00+00:00
- [PETAL Consortium Survival Prognosticators and How Inflammation Impacts Hematopoiesis](https://stenobird.com/podcast/blood-podcast-664776/petal-consortium-survival-prognosticators-and-how-inflammation-impacts-hematopoiesis) — 2026-03-05T17:00:00+00:00
- [Review Series on the Structural Underpinnings of Hemostatic Plugs and Thrombotic Occulsions](https://stenobird.com/podcast/blood-podcast-664776/review-series-on-the-structural-underpinnings-of-hemostatic-plugs-and-thrombotic-occulsions) — 2026-02-26T17:00:00+00:00
- [VTE Risk Model in Children and a Novel Tri-specific T-cell-engager for MM](https://stenobird.com/podcast/blood-podcast-664776/vte-risk-model-in-children-and-a-novel-tri-specific-t-cell-engager-for-mm) — 2026-02-19T17:00:00+00:00
- [CAR-iNKT cell immunotherapy and Jagged2/Notch regulation of HSC](https://stenobird.com/podcast/blood-podcast-664776/car-inkt-cell-immunotherapy-and-jagged2-notch-regulation-of-hsc) — 2026-02-12T18:43:14+00:00
- [Biologic Insights and Clinical Trial Design for AML](https://stenobird.com/podcast/blood-podcast-664776/biologic-insights-and-clinical-trial-design-for-aml) — 2026-02-05T18:59:00+00:00
- [How I Treat Series on Acute Lymphoblastic Leukemia](https://stenobird.com/podcast/blood-podcast-664776/how-i-treat-series-on-acute-lymphoblastic-leukemia) — 2026-01-29T18:23:18+00:00

## Actions

Episode pages expose an explicit `request_transcript` action. A page view does not automatically enqueue transcription.